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Tbjective: The study objective was to assess the results of aortic root reconstruction
sing composite conduits with stented bioprosthetic valves.
ethods: A review was conducted of 275 patients (202 were male, mean age 69 
1 years, range 17–88 years) who underwent aortic root replacement using conduits
onstructed intraoperatively from pericardial valves and impregnated Dacron grafts
etween September 1993 and February 2005. There were 151 patients with degen-
rative aneurysms and 63 patients with atherosclerotic aneurysms; 43 patients had
issections (9 acute type A), 13 patients had endocarditis, and 5 patients had other
athologic conditions. The ascending aorta alone was replaced in 154 patients, a
emiarch reconstruction was performed in 105 patients, and extensive arch recon-
truction was performed in 16 patients. Hypothermic circulatory arrest and an open
istal anastomosis were used in 95% of patients.
esults: Hospital mortality was 17 of 275 patients (6.2%). Four additional patients
1.5%) sustained permanent strokes. Among surviving patients, the rate of stroke
as estimated as 0.85 per 100 patient-years and the rate of significant hemorrhage
as estimated as 0.3 per 100 patient-years. Reoperation for valve failure occurred
n only 1 patient 12 years postoperatively. Long-term survival in men was similar
o that of a normal matched control population, but was significantly lower in
omen (P  .002).
onclusions: Men who recover satisfactorily after reconstruction of the aortic root
ith a stented bioprosthetic valved conduit (6-month survivors) enjoy long-term
utcomes equivalent to that of a normal matched population; the postoperative
ortality rate in women is twice that of a normal population.
urgery of the ascending aorta has been remarkably successful for the last
approximately 40 years. Aortic diseases that threaten catastrophic complica-
tions of rupture or dissection can now be treated with durable operations that
ave a low operative mortality.1,2
Aortic root reconstruction is warranted when a diseased aortic valve is associated
ith a dilated or dissected aortic root or ascending aorta. Elective surgery is also
ndicated in the presence of significant dilatation of the sinuses of Valsalva, the
inotubular junction, or the ascending aorta. In addition, elective root replacement
ay be advisable in a minimally dilated aortic root and ascending aorta if aortic
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 6 1455
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1
A
CDalve disease is associated with a genetic predisposition to
neurysm formation or dissection.
Since Bentall and De Bono introduced the surgical tech-
ique involving composite mechanical valved conduits in
968, various adaptations of the original concept have been
he standard therapy for patients with an aortic root aneu-
ysm.3,4 Because a mechanical valved conduit mandates
ifelong anticoagulation, alternative strategies have been
ought. Valve-sparing operations have become an increas-
ngly appealing alternative in younger patients requiring
ortic root surgery whose life expectancy exceeds the an-
icipated durability of an implanted biological valve. For
lderly patients, in whom biological valves generally last
onger, the use of a conduit constructed in the operating
oom by sewing a bioprosthetic valve to a vascular graft is
he most attractive option.
The objective of this study was to evaluate patients who
ave undergone what we will refer to as a biological Bentall
peration to determine whether the benefit of avoiding
nticoagulation by using a biological valve in the aortic
onduit is offset by the need for reoperation because of
alve deterioration.
aterials and Methods
ince 1988, a composite conduit repair (a modified Bentall pro-
edure) has been undertaken in more than 800 patients at Mount
inai Hospital. A review disclosed 275 patients who underwent
ortic root replacement with a biological valved conduit between
eptember 1993 and February 2005. All patients received biopros-
hetic conduits constructed intraoperatively from pericardial valves
nd impregnated Dacron grafts. The mean age was 69 years (range
7–88 years), and 73% were male (n  202). Table 1 summarizes
he clinical characteristics of the patients.
The institutional review board approved this research; addi-
ional patient consent was not required.
ndications
he principal indication for aortic root reconstruction (Table 1)
as a degenerative aortic aneurysm in 151 patients (55%): of
hese, 9 had annuloaortic ectasia, 7 had a bicuspid valve, and 3 had
arfan syndrome. An atherosclerotic aortic aneurysm was present
n 63 patients (23%); 43 patients (16%) had dissections, one
uarter of which (9) were acute type A; 13 patients (5%) had aortic
alve endocarditis affecting the root; and 5 patients had other
athologic conditions.
Fourteen patients underwent emergency root reconstructions
including 9 for acute type A dissection and 4 with root endocar-
Abbreviations and Acronyms
COPD chronic obstructive pulmonary disease
HCA  hypothermic circulatory arrest
SCP  selective cerebral perfusionitis). Twenty-one patients had urgent procedures because of e
456 The Journal of Thoracic and Cardiovascular Surgery ● Junhortness of breath, anginal pain, or syncope. The remaining 240
atients (87%) underwent elective procedures.
A total of 48 patients (18%) had undergone previous cardio-
ortic procedures; 27 patients (10%) had received oral anticoagu-
ants before the root reconstruction, and 50 patients (18%) had
eceived platelet inhibitors. At hospital admission, 85 patients
31%) were being treated for hypertension with -adrenergic
locking agents, and 49 patients (18%) were being treated with
ngiotensin-converting enzyme inhibitors.
urgical Technique
Cannulation and myocardial protection. Arterial cannulation
as carried out through the femoral artery (19%), the ascending
orta (18%), and, more recently, the right axillary artery (61%;
igure 1) as previously described by our group5; the left axillary
rtery or the aortic arch was cannulated in 6 cases (2%). Venous
annulation was usually through a 2-stage catheter in the right
trium, but in some patients in whom the heart was not fully
xposed, the right atrium was accessed through a wire-directed
atheter placed through the femoral vein. Myocardial protection
as provided with cold antegrade blood cardioplegia, systemic
erfusion at 20°C, and, in patients with severe coronary disease,
etrograde blood cardioplegia. Cardioplegia was administered ev-
ABLE 1. Clinical profile and indication for operation
n (%)
emographics
Mean age y (SD) 69.3 (11.3)
Age 60 y 226 (82%)
Male sex 202 (73%)
Previous cardioaortic operations 48 (18%)
iming of surgery
Elective 240 (87%)
Urgent/emergency 21 (8%)/14 (5%)
isk factors
History of neurologic dysfunction 24 (9%)
History of hypertension 149 (54%)
Coronary artery disease (CAD) 96 (35%)
Smoking/diabetes/COPD 75 (27%)/17 (6%)/8 (3%)
ortic root pathology
Degenerative 151 (55%)
Bicuspid valve/annuloaortic
ectasia/Marfan syndrome
9 (3%)/9 (3%)/3 (1%)
Atherosclerosis 63 (23%)
Dissection 43 (16%)
Acute type A dissection 14 (5%)
Acute endocarditis 13 (5%)
Other* 5 (2%)
ortic valve function/pathology
Aortic regurgitation 167 (61%)
Prosthetic valve 11 (4%)
ntraoperative findings
Clot or atheroma 24 (9%)
D, Standard deviation; CAD, coronary artery disease; COPD, chronic
bstructive pulmonary disease. *Pseudoaneurysm after ascending re-
lacement (n  4) and giant cell aortitis (n  1).ry 20 to 30 minutes during periods of myocardial ischemia.
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A
CDHypothermic circulatory arrest. HCA was effected by surface
cooling blanket) and perfusion cooling. If HCA was anticipated
arly in the procedure, the patient was cooled during the initial
eriod of cardiopulmonary bypass. In some patients in whom HCA
ccurred later in the operative procedure, the patient was main-
ained at a perfusion temperature of 20°C until approximately 15
inutes before HCA, after which the blood temperature was
ecreased to 10°C. Adequate cerebral cooling was ensured in all
ases by cooling for a minimum of 30 minutes, maintaining a
ugular venous saturation greater than 95%, and maintaining an
sophageal temperature of 12°C to 15°C. In all patients in whom
ore than 20 minutes of HCA was anticipated or selective cerebral
erfusion (SCP) was used, the head was packed circumferentially
n ice.
Perfusion warming was performed at the end of the proce-
ure with the gradient between the esophageal and blood tem-
erature maintained at less than 10°C. Warming was maintained
ntil the esophageal temperature reached 35°C and bladder tem-
erature was greater than 32°C. Downward drift, however, re-
ulted in most patients leaving the operating room with esophageal
nd bladder temperatures of 32°C. Warming was usually accom-
lished in 1 hour of perfusion; during the last 15 or 20 minutes,
artial bypass was frequently used to take advantage of improved
arming with pulsatile perfusion.
Selective cerebral perfusion. Perfusion of all 3 head vessels
as achieved with SCP when arch replacement was planned or
erebral protection time was expected to exceed 30 minutes. Once
he use of the trifurcation graft was introduced for arch repair, SCP
as provided by inflow to the trifurcation graft through the right
xillary artery. SCP was performed at a blood temperature of 15°C
o 20°C and flow sufficient to maintain a pressure of 50 to 60 mm
igure 1. Cannulation sites used: technique changes from 1995 to
005.g. This usually required a flow of 800 to 1200 mL/min. c
The Journal of ThoracicAortic root reconstruction. A button Bentall procedure was
sed in 93% of patients, a Cabrol procedure was used in 4% of
atients, and a classic Bentall procedure was used in 3% of patients
Table 2). No valvuloplasty or valve-sparing procedures were
ncluded in this series; in all 275 patients, a stented pericardial
alve (Carpentier-Edwards Perimount series in most cases; Ed-
ards Lifesciences, Irvine, Calif) was used. The Dacron graft was
versized 5 to 7 mm larger than the valve diameter.
nastomotic Technique
roximal anchoring of the Bentall grafts was accomplished with
nterrupted pledgeted sutures. Coronary button anastomoses were
einforced with small strips of Teflon felt. All graft-to-aorta anas-
omoses were performed with a sandwich technique, placing the
ortic wall between the vascular graft and an external band of
eflon felt, as previously described by Strauch and associates.6 All
raft material was albumin-impregnated woven Dacron.
xtent of Operation
nly the ascending aorta was replaced in 152 patients (55%); a
emiarch reconstruction was performed in 102 patients (37%); and
xtensive arch reconstruction was performed in 21 patients (8%),
ith an elephant trunk stage I in 13 cases. Overall cardiopulmo-
ary bypass time was 260  57 minutes. The distal anastomosis
as performed open in more than 95% of the cases (n  262).
etailed operative data are shown in Table 2.
One third of the patients had coronary artery disease requiring
oncomitant bypass grafting (n  101); 15 patients underwent a
ABLE 2. Operative data
ariable %
entall technique
Buttons3/Classic4/Cabrol14 93%/4%/3%
xtent of aortic replacement
Ascending only/hemiarch/arch 55%/37%/8%
/elephant trunk stage I 5%
ardiopulmonary bypass
Cannulation
Right/left axillary artery 61%/1%
Femoral 19%
Ascending/descending aorta 18%/2%
CPB time* 260 (57)
Myocardial ischemia (crossclamp) time* 181 (48)
Cerebral ischemia (HCA) time* 26 (14)
Open distal anastomosis 262 (95%)
Minimal esophageal temperature* 12.5 (2.5)
oncomitant procedures
Coronary artery bypass grafting 37%
Mitral valve procedure 5%
Replacement/repair (annuloplasty/ring) 1%/4%
Other 4%
PB, Cardiopulmonary bypass; HCA, hypothermic circulatory arrest. *Re-
ults are mean  standard deviation. Times are in minutes; temperatures
re in degrees Celsius.oncomitant mitral valve procedure (Table 2).
and Cardiovascular Surgery ● Volume 133, Number 6 1457
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1
A
CDollow-up
ll patients were followed by the referring cardiologist and
ontacted periodically by our research personnel. The follow-up
uestionnaire included cardiac reoperations (paravalvular leak-
ge, prosthetic valve endocarditis), myocardial infarction, ce-
ebral, visceral or peripheral thromboembolic events, hemor-
hage, endocarditis, and anticoagulant intake, and was
ompleted in all cases by the patients themselves, their cardi-
logists, or close family members.
Annual computed tomography scans were scheduled in all
atients and attained in 61% of patients. Postoperative events were
ompiled and analyzed according to the Guidelines for Reporting
orbidity and Mortality after Cardiac Valvular Operations7 and
ur institutional checklist. For this study, follow-up was closed on
ecember 31, 2005, and extended to 11 years.
tatistical Methods
ata were entered in an Excel spreadsheet (Microsoft Corp, Red-
ond, Wash) and transferred to an SAS file (SAS Institute Inc,
ary, NC) for data description and analysis. Patient characteristics
re described as percentages, and groups were compared using
hi-square tests. Early death is defined as death within 30 days
fter the procedure or death before discharge, if beyond 30 days.
ogistic regression analysis was used to study independent factors
ssociated with adverse outcome, early death, or permanent stroke.
or patients who did not experience early death, long-term
ollow-up commences 30 days after the procedure and continues
ntil the date of death, or December 31, 2005, for patients with no
eath information. Kaplan–Meier life tables were calculated to
escribe early and long-term survival. The Cox proportional haz-
ABLE 3. Postoperative complications
ariable n (%)
leeding requiring rethoracotomy* 16 (5.8%)*
ardiac complications 17 (6.1%)
Ventricular tachycardia/AV-block III
(requiring pacemaker)
5 (1.8%)/2 (0.7%)
Myocardial ischemia/infarction (IABP)† 9 (3.3%)†
nfection 5 (1.8%)
Mediastinitis‡/sepsis§ 3 (1.1%)‡/2 (0.7%)§
eurological dysfunction 59 (21.4%)
Temporary (TND, PRIND)/permanent
(stroke)
52 (18.9%)/7 (2.5%)
espiratory insufficiency/tracheotomy 43 (15.6%)/25 (9.1%)
enal failure/temporary dialysis 6 (2.2%)/4 (1.5%)
thers¶ 8 (2.9%)¶
ospital mortality 17 (6.2%)
V, Atrioventricular; IABP, intra-aortic balloon pump; TND, temporary
eurologic dysfunction; PRIND, prolonged reversible ischemic neurologic
eficit. *Requiring revision of distal anastomosis in 1 case and late tam-
onade in 8 cases. †Requiring revision of button anastomosis in 1 case
1%). ‡One omentum transplant for infective mediastinitis on day 30, 1
uscle flap closure over the aortic graft, and sternal revision on day 14.
Both died in hospital (1 candida with embolism). Three died in hospital (4
troke survivors). ¶DVT (1)/peripheral embolism (2)/bowel infarction (2)/
asciotomy after femoral cannulation (1)/colectomy for colitis (2).rds model was used to identify independent risk factors for h
458 The Journal of Thoracic and Cardiovascular Surgery ● Junong-term survival, controlling for age and gender. Long-term
urvival of male and female patients was compared with New
ork State death rates from 2001 for corresponding ages and
erson-years of exposure, and the differences were tested by
ethods for Poisson regression.
The risk factors considered for analysis were age, gender,
istory of hypertension, chronic obstructive pulmonary disease
COPD), coronary artery disease, history of neurologic dysfunc-
ion, aortic regurgitation, urgency of the procedure, pathologic
ondition for which the procedure was indicated, cannulation site,
xtent of procedure, presence of clot or atheroma, open distal
nastomosis, and concomitant procedures (mitral valve replace-
ent/repair, concomitant coronary artery bypass grafting, and
ther concomitant procedures such as tricuspid valve replace-
ent). For long-term analysis, anticoagulant and -adrenergic
locking agent intakes were also considered.
esults
ospital Mortality and Adverse Outcome
he overall hospital mortality, defined as death in the hospital
r within 30 days postoperatively, was 6.2% (n  17). Four
dditional patients (1.5%) sustained permanent strokes. Ad-
erse outcome, defined as stroke or hospital death, occurred in
1 patients (8%): 17 deaths (including 3 patients with strokes)
nd 4 stroke survivors. On analysis of preoperative risk
actors one at a time, there was a statistically significant
ssociation with adverse outcome of coronary artery disease
P  .02), clot or atheroma (P  .0001), and concomitant
rocedure (P  .02, without regard to the type of operation
erformed concomitantly). Among the variables tested, gen-
er, age more than 60 years, COPD, history of hypertension,
igure 2. Oral anticoagulation (Coumadin) at hospital admission
nd discharge after aortic root reconstruction with a biopros-
hetic valved conduit.istory of neurologic symptoms, and severity of aortic re-
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A
CDurgitation did not show evidence of association with ad-
erse outcome in these data.
All known preoperative risk factors were entered in a
tepwise logistic regression analysis to identify those that
ere independent predictors of adverse outcome. Three
actors were identified: clot or atheroma (P  .0004), cor-
nary artery disease (P  .01), and nonelective procedure
P  .03).
ostoperative Complications
evere postoperative complications after bioprosthetic root
econstruction occurred in 68 patients (24.7%) (Table 3).
he most common serious complications were respiratory
nd cardiac. Twenty-one percent of patients had transient
eurologic dysfunction, but only 7 patients had strokes, 3 of
hom died. Six patients required dialysis, which was per-
anent in 2 patients; 4 patients had only transient postop-
rative renal failure.
edication at Hospital Admission and Discharge and
uring Follow-up
t hospital admission, 10% of the patients (n  27) were
Figure 3. Kaplan–Meier survival curve. Survival after ao
male (N  190) and female patients (N  68) versus ag
by Poisson regression with follow-up to 10.7 years.aking low-dose oral anticoagulants (Coumadin/warfarin). y
The Journal of Thoracicverall, 46% of the patients (n 126) were discharged with
ral anticoagulants, usually for 3 months, as suggested by
he valve manufacturers. In recent years, both the number of
atients for whom anticoagulants were prescribed even tran-
iently and the level of anticoagulation have been diminish-
ng (Figure 2). During follow-up, anticoagulation was
ewly initiated in 4% (n  11); long-term anticoagulation
as generally maintained only for indications such as atrial
brillation, unrelated to the presence of the valved conduit.
The number of patients treated with -adrenergic block-
ng agents increased from 26% (72 patients) at admission to
6% (125 patients) at discharge, whereas the number of
ngiotensin-converting enzyme inhibitor-treated patients
id not change.
ate Mortality
ong-term survival among patients who did not die before
ischarge or within 30 days of the procedure was compared
ith New York State 2001 death rates (Figure 3). The median
uration of follow-up was 3.6 years (range 0–10.7 years).
There were 190 men with a median follow-up of 3.5
root reconstruction with bioprosthetic valved conduits:
tched New York State populations. P values obtainedrtic
e-maears (0.01–10.6 years), totaling 703 patient-years; among
and Cardiovascular Surgery ● Volume 133, Number 6 1459
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1
A
CDhese, there were 34 deaths (4.8/100 patient-years). The
eath rate was 1.2 times what would have been expected for
he control population (P  .34). Among the 68 women,
owever, in whom median follow-up was 2.8 years (0.05-
0.7), amounting to 247 patient-years, 21 deaths occurred
8.5/100 patient-years). The death rate in women was twice
hat would have been expected on the basis of the control
roup (P  .002). A woman is therefore 1.7 times as likely
o die after a biological Bentall operation, relative to the
orresponding New York State control rates, than a man
P  .07).
For the group as a whole, multivariate analysis indicated
hat the long-term outcome after a biological valved conduit
econstruction of the aortic root among female patients was
ignificantly worse than that for male patients, and that their
isk factors differed. For female patients, multiregression
nalysis revealed the presence of clot or atheroma as an
ABLE 4. Long-term survival after aortic root reconstructio
irst author/year Bentall technique and conduit n
ehr/20048 “Modified” Bentall
Composite conduits
Mechanical (90%)
Biological (10%)
Valve-preserving
149
54
agl/200315 Button Bentall
Composite conduits
Mechanical (88%)
Biological (12%)
142
65 o
proc
acini/200316 Classic Bentall (34%)
Button Bentall (63%)
Cabrol (3%)
Composite conduits
Mechanical only
274
ellgren/200217 Stentless porcine bioprosthesis 112
70 o
sym
hrlich/200118 Mechanical (N  47) and
biological (N  37) Bentall
84
ount Sinai/2006 Biological Bentall 275
, Multivariate analysis; u, univariate analysis; MV, mitral valve; AV, atriove
atients with composite valve conduit reconstruction versus valve-spari
rocedure or pseudoaneurysm. †Conduit versus valve preservation at 5 y
endocarditis, aortic reoperation, stroke, significant bleeding or thromboendependent predictor of late death. Open distal anastomosis v
460 The Journal of Thoracic and Cardiovascular Surgery ● Junnd prescription of -blocking drugs at hospital discharge
ere protective factors for long-term survival in women. In
ale patients, the presence of COPD and performance of
ny concomitant procedure were independent predictors of
ate death.
ortic Reoperation
wo patients required early revision for mediastinitis after
rimary aortic root reconstruction with a bioprosthetic
alved conduit. No reoperation for early failure of the
iological Bentall procedure or for anastomotic pseudo-
neurysm occurred.
tructural Valve Deterioration
eoperation for structural valve dysfunction was required in
nly 1 patient, 12 years after root replacement with a biological
literature review
e (y) Hospital mortality Survival
(16) 4% 93% (5 y)
79% (10 y)
Predictors of late death:
age,m female, MV
regurgitation;u
concomitant
procedure,u no -blocker,‡
inotropesu
(13-64)
concomitant
e
1% 95% at (5 y)
93% (8 y)
(14.5) 7% 78% (5 y)
63% (10 y)
Predictors of late death:
CAD,m chronic renal
failure,m postoperative
dialysism
 5.0
r
atic
7% 74% (5 y)
38% (9 y)
(66-89)
y
8.3% 74% (5 y)
(11.3) 6.2% 74% (5 y)
Predictors of late death:
female,m concomitant
procedurem
lar; CAD, coronary artery disease. No difference in late survival between
eration. Freedom from reoperation because of a failure of the Bentall
vs 63%, P .001. ‡At admission. §Overall freedom from late adverse event
complications).n: A
Ag
53
46
nly, Ø
edur
53.5
78.5
nly, o
ptom
74
65
69.3
ntricu
ng op
: 96%alved composite graft.
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A
CDhromboembolic Events
even of the 125 patients who were alive at study time
eported having a permanent stroke during follow-up. One
as undergoing long-term anticoagulation for an indication
nrelated to the Bentall procedure. One additional patient
ho died in follow-up is known to have had a stroke,
aking a total of 8 documented strokes among hospital
urvivors, a rate of 0.85 per 100 patient-years of follow-
p. However, we could not update information about
trokes for 39 of the 55 patients who died in follow-up.
f they had experienced strokes at the same rate as the 16
eceased patients with known stroke information, the
inearized stroke rate would be estimated as 1.2 per 100
atient-years.
emorrhage
fter hospital discharge, 3 patients had a significant hem-
ABLE 4. (Continued)
Freedom
Aortic reoperations Thromboemb
88% (5 y)
86% (10 y)†
redictors: Marfan, concomitant procedure,
AV spare
97% (5 y)
96% (10 y)
100%§ 98%
0.3/100 p
99% (5 y)
99% (10 y)
94% (20 y);0.28/100pt-y‡
98% (5 y)
91% (10 y)
90% (20 y);0.6
96% (5 y)
87% (9 y)
89% (5 y)
71% (9 y)
- 2.1/100 p
0.0/100 pt-y 0.85/100rrhage as defined by the Society of Thoracic Surgeons t
The Journal of Thoracicuidelines. All 3 were alive at study time. Two of them were
eing treated with anticoagulants for indications unrelated
o the biological Bentall procedure. The linearized inci-
ence of significant hemorrhage during follow-up was es-
imated as 0.3 per 100 patient-years. The median time to
emorrhage was 503 days (498–2016 days).
iscussion
his review of our experience with reconstruction of the
ortic root using a stented bioprosthetic valve in the
onduit yielded a number of interesting insights. Overall,
he study revealed favorable short and long-term out-
omes in these elderly patients. The absence of valve
ailure within the first 10 years and the low incidence of
omplications make a biological Bentall operation seem
ot only an attractive alternative to aortic root replace-
ent using a mechanical valved conduit but also raises
/rate of
Hemorrhage Endocarditis
3% (15 y) 99% (15 y)
Overall: 85% (5 y)/78% (8y)‡
93%
1.6/100 pt-y
99%
0.3/100 pt-y
pt-y
100% (5 y)
87% (10 y)
74% (20 y);0.91/100pt-y
98% (5 y)
96% (20 y);0.35/100 pt-y
99% 96% (5 y)
90% (9 y)
—
0.3/100 pt-y 0.0/100 pt-yfrom
olism
t-y
3/100
t-y
pt-yhe question whether biological valved conduit replace-
and Cardiovascular Surgery ● Volume 133, Number 6 1461
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1
A
CDent may be preferable in some situations to a valve-
paring operation.
Because the main advantage of implanting a biological
alved conduit compared with a mechanical valve is to
void anticoagulation, we were startled to see that so many
f our patients, especially in the earlier years of this expe-
ience, were discharged with anticoagulants. Postoperative
atient care in our referral practice is largely the province of
ardiologists, who generally think that a 3-month interval of
nticoagulation postoperatively is a good idea to guard
gainst thromboembolism until the conduit endothelializes
ully. Only a small minority of patients remained on anti-
oagulation long term for reasons unrelated to the conduit
chiefly atrial fibrillation), but the levels of anticoagulation
eeded for this indication are lower than those considered
andatory to prevent thrombosis of a mechanical valve.
nly 18% of the population received platelet inhibitors,
erhaps because only 23% of the patients had atheroscle-
otic aneurysms and were therefore deemed likely to benefit
rom antiplatelet therapy. We were gratified to see a low rate
f embolic, thrombotic, and hemorrhagic complications and
n absence of early biological valve failure during long-
erm follow-up.
Long experience has indicated that tissue valves un-
ergo accelerated degeneration in young individuals, but
t may be that newer techniques of valve preservation
ake a biological prosthesis a reasonable option begin-
ing in early middle age. The greater ease of operation
ompared with valve-sparing procedures, the absence of
arly valve failure even when preoperative aortic insuf-
ciency has been moderate or severe, and the lack of
orry about early degeneration when a connective tissue
isorder is present make biological valved graft replace-
ent appealing.
The importance of clot or atheroma observed intraoper-
tively underlines the importance of embolization in deter-
ining both short- and long-term adverse outcomes after
ortic root replacement regardless of method. One of the
esults we anticipated was that axillary cannulation would
merge as a factor reducing the risk of embolization (and
herefore of adverse outcome) in these patients, many of
hom have a high risk of stroke because of underlying
therosclerosis. During the last 5 years of the study, axillary
annulation was used predominantly because the axillary
rtery is rarely—in contrast with the ascending aorta or
emoral artery—affected by severe atherosclerosis. Al-
hough the low rate of adverse outcome in the relatively
mall number of patients with different cannulation tech-
iques did not permit the identification of axillary artery
annulation as a significant factor contributing to long-term
urvival, we did observe that the rate of adverse outcome
uring the last 5 years of the series, when axillary artery
annulation was the technique of choice, decreased to 5.1%. f
462 The Journal of Thoracic and Cardiovascular Surgery ● Junn addition to its perceived advantage in preventing embo-
ization, the axillary artery also provides an excellent route
or SCP, which may be required in high-risk cases for
erebral protection. Axillary artery cannulation also dimin-
shes the risk of reentry into a previously operated chest by
llowing rapid initiation of cardiopulmonary bypass.
Another potentially important but somewhat unexpected
nding of this study is that the long-term outcome of female
atients who survive root replacement with a biological
alved conduit is different—and worse—than the outlook
or male patients, if compared with an age-matched popu-
ation. As noted in Table 4, Zehr and colleagues8 found
emale gender to be a univariate predictor of late death in a
ignificantly younger population with the same male:female
25%) ratio. Male patients who recover satisfactorily after
econstruction of the aortic root with a biological valved
onduit enjoy long-term outcome equivalent to that of a
ormal age-matched population, but women who survive
he biological Bentall procedure are twice as likely to die
uring follow-up than their age-matched normal peers. This
nding is in accord with similar observations after com-
ined valve and coronary artery bypass surgery, after which
orbidity and mortality are less favorable for women than
or men.9–11 The difference in the prognosis for men and
omen after aortic root operation may represent a differ-
nce in the pathophysiology leading to surgery in men and
omen: Only 31% of the male patients had an atheroscle-
otic aneurysm (n  35; 17%) or dissection (n  27; 13%),
n contrast with 60% of female patients with atherosclerotic
neurysm (n  28; 38%) or dissection (n  16; 22%).
An increased propensity to develop degenerative an-
urysm disease in men was found in several series.12,13
lthough degenerative disease can affect the entire vas-
ular system (as in Marfan syndrome), localized degen-
rative aortic aneurysm disease (eg, bicuspid valve dis-
ase) may be considered cured once the aortic root has
een resected and is therefore unlikely to affect long-
erm survival. The relatively high mean age and the low
ercentage of Marfan disease may reflect an unusually
igh proportion of localized degenerative disease in the
en in this series. In contrast, an atherosclerotic root
neurysm, or a dissection—which accounted for a much
igher proportion of the cases in women—may reflect
ore severe and widespread disease. In the majority of
he female patients, although resection of the root aneu-
ysm eliminated the risk of localized rupture or dissec-
ion, a propensity for dissection or widespread athero-
clerotic disease likely continued to be a threat in other
egments of the vascular system.
This theory to explain our results is supported by the
nding that the presence of clot and atheroma in the aortic
oot was the most significant predictor of late death in
emale patients. The fact that an open distal anastomosis
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A
CDnhanced long-term outcome is consistent with the known
isks of crossclamping the aorta in the presence of athero-
clerosis or dissection. Similarly, that the use of -adrener-
ic blocking agents improved long-term survival in women
akes sense if many of them had ongoing serious cardio-
ascular pathologic conditions. It is also likely that women
re referred later for aneurysm surgery, because the major
ndication for elective operation is the extent of aortic
ilatation, which is usually measured in absolute terms
ather than being indexed to the size of the patient. It seems
lausible that a 6-cm aorta reflects more advanced disease in
petite woman than in an average (much larger) man.
In men, COPD and any concomitant procedures inde-
endently predicted late death after the biological Bentall
rocedure. Nevertheless, longevity for male survivors did
ot differ from the expected mortality rate in an elderly
ge-matched control population.14,15
onclusions
he excellent results after implantation of bioprosthetic
alved conduits for patients requiring aortic root reconstruc-
ion may lead to an expansion of the indications for this
rocedure. In patients for whom anticoagulation is contra-
ndicated or undesirable, reconstruction of the aortic root
ith a stented bioprosthetic valved conduit offers an excel-
ent alternative to the use of a mechanical valved prosthesis
nd may be preferable to a valve-sparing operation in
iddle-aged and older individuals, those with connective
issue disorders, and those with more than mild aortic in-
ufficiency preoperatively.
eferences
1. Detter C, Mair H, Klein HG, Georgescu C, Welz A, Reichart B.
Long-term prognosis of surgically-treated aortic aneurysms and dis-
sections in patients with and without Marfan syndrome. Eur J Car-
diothorac Surg. 1998;13:416-23.
2. Lepore V, Larsson S, Bugge M, Mantovani V, Karlsson T. Replace-
ment of the ascending aorta with composite valve grafts: long term
results. J Heart Valve Dis. 1996;5:240-6.
The Journal of Thoracic3. Kouchoukos NT, Wareing TH, Murphy SF, Perrillo JB. Sixteen-year
experience with aortic root replacement. Results of 172 operations.
Ann Surg. 1991;214:308-18; discussion 18-20.
4. Bentall H, De Bono A. A technique for complete replacement of the
ascending aorta. Thorax. 1968;23:338-9.
5. Strauch JT, Spielvogel D, Lauten A, Lansman SL, McMurtry K,
Bodian CA, et al. Axillary artery cannulation: routine use in ascending
aorta and aortic arch replacement.Ann Thorac Surg. 2004;78:103-8;
discussion 103-8.
6. Strauch JT, Spielvogel D, Lansman SL, Lauten AL, Bodian C, Griepp
RB. Long-term integrity of Teflon felt-supported suture lines in aortic
surgery. Ann Thorac Surg. 2005;79:796-800.
7. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC,
Weisel RD. Guidelines for reporting morbidity and mortality after
cardiac valvular operations. Eur J Cardiothorac Surg. 1996;10:812-6.
8. Zehr KJ, Orszulak TA, Mullany CJ, Matloobi A, Daly RC, Dearani JA,
et al. Surgery for aneurysms of the aortic root: a 30-year experience.
Circulation. 2004;110:1364-71.
9. Hassan A, Chiasson M, Buth K, Hirsch G. Women have worse
long-term outcomes after coronary artery bypass grafting than men.
Can J Cardiol. 2005;21:757-62.
0. Doenst T, Ivanov J, Borger MA, David TE, Brister SJ. Sex-specific
long-term outcomes after combined valve and coronary artery surgery.
Ann Thorac Surg. 2006;81:1632-6.
1. Ibrahim MF, Paparella D, Ivanov J, Buchanan MR, Brister SJ. Gender-
related differences in morbidity and mortality during combined valve
and coronary surgery. J Thorac Cardiovasc Surg. 2003;126:959-64.
2. Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC,
et al. Replacement of the aortic root in patients with Marfan’s syn-
drome. N Engl J Med. 1999;340:1307-13.
3. Okita Y, Ando M, Minatoya K, Tagusari O, Kitamura S, Nakajjma N,
et al. Early and long-term results of surgery for aneurysms of the
thoracic aorta in septuagenarians and octogenarians. Eur J Cardiotho-
rac Surg. 1999;16:317-23.
4. Cabrol C, Pavie A, Gandjbakhch I, Villemot JP, Guiraudon G, Laugh-
lin L, et al. Complete replacement of the ascending aorta with reim-
plantation of the coronary arteries: new surgical approach. J Thorac
Cardiovasc Surg. 1981;81:309-15.
5. Hagl C, Strauch JT, Spielvogel D, Galla JD, Lansman SL, Squitieri R,
et al. Is the Bentall procedure for ascending aorta or aortic valve
replacement the best approach for long-term event-free survival? Ann
Thorac Surg. 2003;76:698-703; discussion 703.
6. Pacini D, Ranocchi F, Angeli E, Settepani F, Pagliaro M, Martin-
Suarez S, et al. Aortic root replacement with composite valve graft.
Ann Thorac Surg. 2003;76:90-8.
7. Dellgren G, Eriksson MJ, Brodin LA, Radegran K. Eleven years’
experience with the Biocor stentless aortic bioprosthesis: clinical and
hemodynamic follow-up with long-term relative survival rate. Eur
J Cardiothorac Surg. 2002;22:912-21.
8. Ehrlich MP, Ergin MA, McCullough JN, Lansman SL, Galla JD,
Bodian CA, et al. Favorable outcome after composite valve-graft
replacement in patients older than 65 years. Ann Thorac Surg. 2001;
71:1454-9.
and Cardiovascular Surgery ● Volume 133, Number 6 1463
